Category Human Rights

EU Telecom Package Agreed With Safeguards But Three-Strikes Still Possible

A compromise was found last week between the European Parliament and European Council on “internet access safeguards” in the last remaining open issue in the European Union telecommunications package, according to the Parliament. But public interest concerns remain that restrictive punishment measures might still be possible.

Changing Winds For Gene Patenting In the US? Stakeholders React To Draft Report

A United States health department advisory group this month produced a new draft report on gene patenting and licensing with recommendations suggesting that excessive patenting can limit patients’ access to gene testing and might not foster genetic research. The recommendations were supported by a variety of health professionals but put the biotechnology industry on edge.

Advocates Warn Against ‘Monsantosizing’ Of Global Food Sources

As the United Nations Special Rapporteur on the right to food prepares to present his report today at the United Nations General Assembly in New York, a global appeal is being filed by farmers and environmental organisations against patents on plants and animals derived from conventional breeding.

Panel Calls For An Ethical Framework For IP And Climate Change

BANGKOK - Normal negotiation strategy is unlikely to result in an impact on climate change, since the most important stakeholders in fighting it - not yet born - have no seat at the negotiating tables, said a panel last week in Bangkok. An ethical approach is a better way to achieve results, speakers said, and an ethical take on intellectual property rights and alternative forms of innovation may have a place in new climate-friendly economic models.

专家组:获取安全药品是公共卫生问题而非知识产权问题

在最近由开放社会协会(Open Society Institute)主办的一次会议上,与会专家表示,反假冒倡议可能阻碍人们获得药品,但无法解决假药问题,在发展中国家尤其如此。

Grupo de expertos considera que el acceso a los medicamentos seguros es una cuestión de salud pública y no de propiedad intelectual

Las iniciativas de lucha contra la falsificación podrían dificultar el acceso a los medicamentos sin que se logre paliar el problema de los fármacos falsificados, en particular en los países en desarrollo, según dijeron miembros de un grupo de expertos en un evento organizado recientemente por el Open Society Institute.

WTO Forum: Bypassing International Agreements May Hamper Medicines Access

Access to medicines in developing countries may be put at risk by European customs regulations and more broadly by trade provisions in most free trade agreements between developed and developing countries, said speakers at the recent World Trade Organization Public Forum.

IP Rights In Agriculture: High Stakes, Entrenched Positions At WTO Public Forum

The economic, climate and food crises were on the lips of speakers at the 2009 World Trade Organization Public Forum last week. Suggestions for better global governance were sought from stakeholders who took the podium in different sessions, and trade in agriculture was a focal point of the event.

Iceland Panel: French ‘3-Strike’ Rule Spreading But Not Best Option

COPENHAGEN - A panel discussing the copyright challenges posed by social media at a recent conference in Iceland concluded that while new and stricter regulations as proposed in France may not be a bad idea, the best solution is to provide consumers with quality services for which they are willing to pay. Meanwhile, there are new developments at the European level.

Access To Safe Medicine A Public Health Issue, Not IP, Says Panel

Anti-counterfeiting initiatives might have a negative impact on access to medicines while not addressing the problem of fake medicines, particularly in developing countries, according to panellists at a recent event organised by the Open Society Institute.